Loading clinical trials...
Loading clinical trials...
The purpose of this study is to establish the natural history of of participants with BESTROPHIN 1 Vitelliform Macular Dystrophy. The blinding disorder Best Vitelliform Macular Dystrophy (VMD) is cau...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Columbia University
Collaborators
NCT07548944 · Retinitis Pigmentosa (RP), Usher Syndrome, and more
NCT05926583 · Retinitis Pigmentosa
NCT07174726 · X-Linked Retinitis Pigmentosa (XLRP)
NCT07292987 · Retinitis Pigmentosa (RP)
NCT06789445 · Primary Photoreceptor Disease, Retinitis Pigmentosa (RP), and more
Columbia University Irving Medical Center
New York, New York
Institut de la Vision/Centre de maladies rares du Centre Hospitalier National Ophtalmologique des Quinze-Vingts
Paris
Eberhard Karls University Tubingen
Tübingen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions